New Key Statistics Module, Z-Score and F-Score
NAS:SEEL Key Ratios
Market Cap $ M | 4.52 |
Enterprise Value $ M | 15.64 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.54 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -13.73 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 51.30 |
5-y EBITDA Growth Rate % | 47.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.42 |
EV-to-EBITDA | -0.42 |
PEG | -- |
Shares Outstanding M | 13.68 |
Net Margin (%) | -4,588.37 |
Operating Margin % | -4,912.25 |
Pre-tax Margin (%) | -4,588.37 |
Quick Ratio | 0.14 |
Current Ratio | 0.14 |
ROA % (ttm) | -265.15 |
ROE % (ttm) | -- |
ROIC % (ttm) | -155.81 |
Dividend Yield % | -- |
Altman Z-Score | -95.02 |
Piotroski F-Score | 4.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
SEEL Number of Guru Trades
SEEL Volume of Guru Trades
Gurus Latest Trades with NAS:SEEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SEEL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Seelos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SEEL
Total 0- 1